These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20382150)

  • 41. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
    Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
    Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alteration of the aPA ELISA by UV exposure of polystyrene microtiter plates.
    Goldberg JS; Wagenknecht DR; McIntyre JA
    J Clin Lab Anal; 1996; 10(5):243-9. PubMed ID: 8887002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus.
    Sanfilippo SS; Khamashta MA; Atsumi T; Amengual O; Bertolaccini ML; D'Cruz D; Amft N; Swana GT; Hughes GR
    J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W; Matthias T; Scharrer I
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies.
    Sugi T; Mclntyre JA
    Thromb Haemost; 1996 Sep; 76(3):354-60. PubMed ID: 8883270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases.
    Merkel PA; Chang Y; Pierangeli SS; Harris EN; Polisson RP
    J Rheumatol; 1999 Mar; 26(3):591-6. PubMed ID: 10090168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis.
    Harrison CN; Donohoe S; Carr P; Dave M; Mackie I; Machin SJ
    Thromb Haemost; 2002 May; 87(5):802-7. PubMed ID: 12038780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A sensitive assay for anti-phosphatidylethanol-amine antibody in patients with recurrent fetal loss.
    Hayashi Y; Aoki K; Kunimatsu M; Sasaki M; Yagami Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Nov; 42(11):1565-70. PubMed ID: 2273313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome.
    Blank M; Krause I; Magrini L; Spina G; Kalil J; Jacobsen S; Thiesen HJ; Cunningham MW; Guilherme L; Shoenfeld Y
    Rheumatology (Oxford); 2006 Jul; 45(7):833-41. PubMed ID: 16705050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of complement-fixing antiphospholipid antibodies in association with thrombosis.
    Munakata Y; Saito T; Matsuda K; Seino J; Shibata S; Sasaki T
    Thromb Haemost; 2000 May; 83(5):728-31. PubMed ID: 10823270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
    Sahin M; Duzgun N; Tunc SE; Tutkak H
    Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when beta 2-glycoprotein I is bound to a suitable surface.
    Pengo V; Biasiolo A; Fior MG
    Thromb Haemost; 1995 Jan; 73(1):29-34. PubMed ID: 7537919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ELISA for the detection of anticardiolipin antibodies. High specificity based on the use of adult bovine serum as buffer and systematic subtraction of non-specific binding.
    Rupin A; Gruel Y; Watier H; Girard AC; Leroy J; Bardos P
    J Immunol Methods; 1991 Apr; 138(2):225-31. PubMed ID: 2033275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early endosome as a pathogenic target for antiphosphatidylethanolamine antibodies.
    Hou S; Fölsch H; Ke K; Cook Mills J; Ramsey-Goldman R; Zhao M
    Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13798-13803. PubMed ID: 29229837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microtitre plate and assay buffer alter detection of antiphosphatidylethanolamine antibodies in lupus anticoagulant positive plasma.
    Drouvalakis KA; Buchanan RR
    Thromb Res; 1999 May; 94(4):205-12. PubMed ID: 10336235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advantage of using both anionic and zwitterionic phospholipid antigens for the detection of antiphospholipid antibodies.
    Laroche P; Berard M; Rouquette AM; Desgruelle C; Boffa MC
    Am J Clin Pathol; 1996 Oct; 106(4):549-54. PubMed ID: 8853046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methodological approach for the detection of IgM anticardiolipin antibodies.
    Rupin A; Gruel Y; Leroy J; Bardos P
    Immunol Invest; 1992 Apr; 21(2):159-67. PubMed ID: 1582679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibodies to phosphatidylethanolamine and phosphatidylserine are associated with increased natural killer cell activity in non-male factor infertility patients.
    Sher G; Fisch JD; Maassarani G; Matzner W; Ching W; Chong P
    Hum Reprod; 2000 Sep; 15(9):1932-6. PubMed ID: 10966989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.